Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
Auction 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Alector, Inc. - Common Stock
(NQ:
ALEC
)
1.160
+0.050 (+4.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alector, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Why Edible Garden Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 13, 2023
Edible Garden AG Incorporated (NASDAQ: EDBL) shares fell on Monday following third-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 13, 2023
Via
Benzinga
Alector to Participate in the Stifel Healthcare Conference
November 08, 2023
From
Alector, Inc.
Via
GlobeNewswire
Analyst Expectations for Alector's Future
September 22, 2023
Via
Benzinga
Expert Ratings for Alector
August 11, 2023
Via
Benzinga
Preview: Alector's Earnings
August 02, 2023
Via
Benzinga
Alector Reports Third Quarter 2023 Financial Results and Provides Business Update
November 07, 2023
From
Alector, Inc.
Via
GlobeNewswire
Alector Announces Achievement of Target Enrollment in the Pivotal INFRONT-3 Phase 3 Clinical Trial of Latozinemab in Individuals with Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)
October 27, 2023
From
Alector, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For September 25, 2023
September 25, 2023
Via
Benzinga
Analyst Expectations for Alector's Future
May 05, 2023
Via
Benzinga
Alector Reduces Workforce To Support Recent Reprioritizing Plans
March 30, 2023
Via
Benzinga
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
September 25, 2023
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 25, 2023
Via
Benzinga
Alibaba, Standard Lithium, Anterix And Other Big Stocks Moving Higher On Friday
September 22, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining 100 points on Friday. Here are some big stocks recording gains in today’s session. Lifezone Metals Limited (NYSE: LZM) surged 27.4% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Expectations for Alector's Future
March 02, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 22, 2023
September 22, 2023
Via
Benzinga
How The Same Treatments May Work For Multiple Neurodegenerative Diseases
September 21, 2023
Extensive research on NDDs has uncovered a different treatment pathway that's enabling some biotechnology firms to target more than one NDD with the same drug candidate.
Via
Talk Markets
Alector Announces Completion of Enrollment in the INVOKE-2 Phase 2 Clinical Trial of AL002, a TREM2 Monoclonal Antibody, in Individuals With Early Alzheimer’s Disease
September 07, 2023
Data readout expected in Q4 2024
From
Alector, Inc.
Via
GlobeNewswire
Alector to Participate in Upcoming Healthcare Conferences
August 31, 2023
From
Alector, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
August 04, 2023
Via
Benzinga
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
August 04, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
August 04, 2023
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
August 03, 2023
Via
Benzinga
Alector Reports Second Quarter 2023 Financial Results and Provides Business Update
August 03, 2023
From
Alector, Inc.
Via
GlobeNewswire
Alector to Host Mid-Year Earnings Conference Call
July 27, 2023
Call Scheduled for Thursday, August 3, 2023, at 4:30 p.m. ET/1:30 p.m. PT
From
Alector, Inc.
Via
GlobeNewswire
7 Stocks That AI Says Will Make You a Millionaire by 2025
July 13, 2023
These seven millionaire-maker stocks are changing hands at deeply undervalued levels. As their growth re-accelerates, so will your portfolio.
Via
InvestorPlace
Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
June 06, 2023
From
Alector, Inc.
Via
GlobeNewswire
Alector Reports First Quarter 2023 Financial Results and Provides Business Update
May 04, 2023
From
Alector, Inc.
Via
GlobeNewswire
Alector to Participate in the BofA Securities 2023 Healthcare Conference
May 02, 2023
From
Alector, Inc.
Via
GlobeNewswire
Alector to Participate in Upcoming Healthcare Conferences
March 01, 2023
From
Alector, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.